Rein Therapeutics Inc
RNTX
$0.79+0.53%
End of day · as of Sep 12, 2026, 8:18 AM ET
Mkt cap
$80.62M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
N/A
EPS (TTM)
$-1.96
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Rein Therapeutics Inc (RNTX) is a biotechnology company listed on NASDAQ.
Latest reported RNTX revenue for 2025-12-31 was $0. Net income was -$49.9M. RNTX currently screens at market cap $80.6M.
Use this RNTX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full RNTX income, balance, and cash tables.
Rein Therapeutics Inc (RNTX) is a biotechnology company in the Healthcare sector.
Latest cached Rein Therapeutics Inc (RNTX) net income for Dec 31, 2025 was -$49.9M. Statements: https://lician.com/financials/rntx
Rein Therapeutics Inc (RNTX) market capitalization is $80.6M on the latest cached snapshot.
Rein Therapeutics Inc (RNTX) cached previous close $0.78; day range $0.77 – $0.81; volume 270,560. Session quote: https://lician.com/quote/rntx
Rein Therapeutics Inc (RNTX) latest cached earnings event is "RNTX earnings" on Aug 14, 2026. Earnings calendar: https://lician.com/earnings